LAST PRICE - AT THE CLOSE
CURE is UP 6% since the begininning of the year
CURE is DOWN -0% BELOW 20 day SMA
CURE is UP 13% ABOVE 200 day SMA
PROFITABLE: N/A
EPS: N/A
EARNINGS MOMENTUM: N/A
N/A INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: N/A
 |
THE STOCK IS 21.2% AWAY FROM ALL-TIME HIGHS OF $149.575 |
 |
CURE IS UP 6% SINCE THE BEGINNING OF THE YEAR |
 |
CURE IS UP 66% OVER THE PAST 12 MONTHS |
 |
CURE IS DOWN -4% OVER THE PAST 1 MONTH |
 |
N/A% OF ALL CURE INVESTORS ARE BETTING AGAINST CURE |
 |
NUM INVESTORS SHORT CURE HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|---|---|
 | New premarket high. ... | 08/03 |
 | New premarket low. ... | 08/03 |
 | Up 4% for the day. | 08/03 |
 | Trading 1% below exp... | 08/03 |
 | Currently at 1 x ave... | 08/03 |
 |
CURE moved down 0.56 in the previous minute |
 |
CURE is up 0 over the last hour |
 |
CURE is up 0.8% over the last 5 days |
 |
CURE is 2 above its 8 day SMA |
| $116.01 |   DAY |
$123.31 |
| $115.00 |  PREVIOUS DAY |
$119.85 |
| $115.00 | WEEK |
$132.00 |
| $107.59 | MONTH |
$132.00 |
| $66.00 | YEAR |
$132.00 |
CURE is mentioned N/A less than normal on 
CURE is mentioned N/A times in an average day on 
